Pharmacist impact on posttraumatic seizure prophylaxis in patients with head injury

Pharmacotherapy

Volumn 22, Issue 2, 2002, Pages 251-255

  Brophy, Gretchen M ^a   Tesoro, Eljim P ^b   Schrote, Gretchen L ^a   Garnett, William R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; PHENYTOIN;

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG COST; FEMALE; HEAD INJURY; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; PHARMACIST; PROPHYLAXIS; SEIZURE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; ANTICONVULSANTS; CRANIOCEREBRAL TRAUMA; EDUCATION, PHARMACY; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACISTS; PHENYTOIN; RETROSPECTIVE STUDIES; SEIZURES; TIME FACTORS;

EID: 0036154032     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.3.251.33547     Document Type: Article

References (8)

1. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures
2. The joint section on neurotrauma and critical care. Role of antiseizure prophylaxis following head injury
3. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit
4. Appropriateness of antiepileptic drug level monitoring
5. Influence of clinical pharmacist consultations on the use of drug blood level tests
6. Collaborative clinical pharmacokinetic services
7. Effect of pharmacist intervention on the use of serum drug assays
8. Pharmacist impact on phenytoin concentration monitoring in the neuroscience intensive care unit